Therapeutic Asset Ratings
191 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
TRIPRO-AMYLIN
Alzheimer Disease
Boston University
Early P1
C
(34)
18F-Fluselenamyl
Alzheimer Disease
Washington University School of Medicine
D
(28)
18F-SMBT1
Alzheimer Disease
The Methodist Hospital Research Institute
D
(28)
Aβ 1-40
Alzheimer Disease
University Hospital, Tours
N/A
D
(28)
BLOOD, WHOLE
Alzheimer Disease
Centre Hospitalier Universitaire, Amiens
N/A
D
(28)
Calcium folinate pentahydrate
Alzheimer Disease
Chung Shan Medical University
N/A
D
(28)
DEXKETOPROFEN
Alzheimer Disease
IRCCS Centro Neurolesi Bonino Pulejo
N/A
D
(28)
Eloxatin
Alzheimer Disease
Chung Shan Medical University
N/A
D
(28)
FLUOROURACILUM
Alzheimer Disease
Chung Shan Medical University
N/A
D
(28)
Hydrogen
Alzheimer Disease
Wonju Severance Christian Hospital
N/A
D
(28)
Lactate
Alzheimer Disease
University of Kansas Medical Center
D
(28)
METAMIZOLE
Alzheimer Disease
IRCCS Centro Neurolesi Bonino Pulejo
N/A
D
(28)
NEPENTHE
Alzheimer Disease
IRCCS Centro Neurolesi Bonino Pulejo
N/A
D
(28)
PANTOPRAZOLE
Alzheimer Disease
Chung Shan Medical University
N/A
D
(28)
TZ-3321
Alzheimer Disease
Washington University School of Medicine
D
(28)
DUVAX
Alzheimer Disease
Nuravax, Inc.
P1
NR
(0)
Showing 176 to 191 of 191 assets
Previous
Page 8 of 8
Next
